Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NDA filed for Keppra XR extended-release tablets

Jan. 16, 2008

Amkor's stroke drug nears end of phase I and prepares for phase II in 2008

Jan. 16, 2008

Readthrough AChE splice variant may be linked to Abeta pathology in AD

Jan. 16, 2008

Novel psychopharmacologic drugs described

Jan. 15, 2008

Diamyd submits IND for phase I novel chronic pain therapy trial

Jan. 15, 2008

Hemispherx submits responses to FDA questions on NDA for Ampligen for CFS

Jan. 15, 2008

Cadence reports topline results from the 301 and 302 phase III clinical trials of Acetavance

Jan. 15, 2008

Intranasal versus i.v. orexin-A in memory enhancement of sleep-deprived monkeys

Jan. 15, 2008

Potent analgesic activity of ABT-102 in preclinical studies

Jan. 15, 2008

Recent patents describe novel agents for neurological disorders

Jan. 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.